A manufacturer has a WDA as does its’ 3rd party logistics provider (3PL). The 3PL was intending to decommission medicines on behalf of the manufacturer but the manufacturer wants to do all decommmissioning
MHRA stated on 25-Sep-17 at the SecurMed presentation in Twickenham that decommissioning directly by manufacturers in the NMVS or EMVS for Article 23 customers would not be allowed.